Papers on
vezatin
VEZT as a novel independent prognostic factor in gastric cancer.Li et al., In Cancer Biomark, 2014
METHODS: We examined the vezatin expression levels in 119 gastric cancer tissues and adjacent normal tissues by immunohistochemistry. Furthermore, we evaluated the expression of VEZT and its relationship with clinicopathological factors, lymphatic metastasis and prognostic value for gastric cancer.